Skip to main content
Log in

Fungal urinary tract infection: patient risk factors determine treatment

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jacobs LG. Fungal urinary tract infections in the elderly. Treatment guidelines. Drugs Aging 1996; 8(2): 89–96

    Article  PubMed  CAS  Google Scholar 

  2. Fisher JF, Newman CL, Sobel JD. Yeast in the urine: solutions for a budding problem. Clin Infect Dis 1995; 20: 183–9

    Article  PubMed  CAS  Google Scholar 

  3. Schaberg DR, Culver DH, Gaynes RR. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 Suppl. 3B: 72S–5S

    Article  PubMed  CAS  Google Scholar 

  4. Hsu CCS, Ukleja B. Clearance of Candida colonizing the urinary bladder by a two-day amphotericin B irrigation. Infection 1990; 18: 280–2

    Article  PubMed  CAS  Google Scholar 

  5. Fisher JF, Chew WH, Shadomy S, et al. Urinary tract infections due to Candida albicans. Rev Infect Dis 1982; 4: 1107–18

    Article  PubMed  CAS  Google Scholar 

  6. Schonebeck J. Asymptomatic candiduria: prognosis, complications, and some other clinical considerations. Scand J Urol Nephrol 1972; 6: 136–46

    Article  PubMed  CAS  Google Scholar 

  7. Jacobs LG, Skidmore EA, Cardoso LA, et al. Bladder irrigation with amphotericin B for treatment of fungal urinary tract infections. Clin Infect Dis 1994; 18: 313–8

    Article  PubMed  CAS  Google Scholar 

  8. Jacobs LG, Skidmore EA, Freeman K, et al. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin Infect Dis 1996; 22: 30–5

    Article  PubMed  CAS  Google Scholar 

  9. Frye KR, Donovan JM, Drach GW. Torulopsis glabrata urinary infections: a review. J Urol 1988; 139: 1245–9

    PubMed  CAS  Google Scholar 

  10. Rivett AG, Perry JA, Cohen J. Urinary candidiasis: a prospective study in hospital patients. Urol Res 1986; 14: 183–6

    Article  PubMed  CAS  Google Scholar 

  11. Grant SM, Clissold SP. Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990; 39: 877–916

    Article  PubMed  CAS  Google Scholar 

  12. Rogers TE, Galgiani JN. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother 1986; 30: 418–22

    Article  PubMed  CAS  Google Scholar 

  13. Leu H-S, Huang C-T. Clearance of funguria with short-course antifungal regimens: a perspective, randomized, controlled study. Clin Infect Dis 1995; 20: 1152–7

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fungal urinary tract infection: patient risk factors determine treatment. Drugs Ther. Perspect 7, 8–10 (1996). https://doi.org/10.2165/00042310-199607120-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607120-00003

Keywords

Navigation